Beta Blocker May Shield Women From Migraine-Linked Strokes
Conexiant
February 3, 2025
Propranolol treatment was linked to a lower risk of ischemic stroke in women with migraines, especially those without aura.
The study analyzed over 3 million medical records, revealing stroke risk reduction of 39% to 52% for women on propranolol.
No significant association between propranolol and stroke risk was found in men with migraines.
Migraine affects women three times more than men and is associated with increased stroke risk.
The study's findings will be presented at the American Stroke Association's International Stroke Conference in February 2025.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Editor
Affiliations:
Specialties:
Areas of Expertise: